Paul Levesque

President and CEO at Theratechnologies Inc.

View articles by Paul Levesque

Innovative Orphan Medicines Require a Transformative Approach to Access and Affordability

Innovative Orphan Medicines Require a…

April 17, 2019

119 likes4 comments

Could gene therapy transform millions of lives?

Could gene therapy transform millions of…

February 28, 2019

559 likes11 comments

Reflecting on Scientific Advances that Improve Patient Care

Reflecting on Scientific Advances that…

September 6, 2018

77 likes3 comments

Here for the Rare Disease Community

Here for the Rare Disease Community

February 28, 2018

150 likes6 comments